(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MEDIMPACT DIRECT SPECIALTY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

MEDIMPACT DIRECT SPECIALTY

ST13

US500000086872778

Classe

35, 42, 44

Pedido

86872778

Registro

5277219

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

01/05/2025

Tipo de marca

Verbal

Classes Nice

35, 42, 44

Data de depósito

12/01/2016

Data de registro

29/08/2017

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/04/2024

Última transação

01/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

705

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

02/06/2014

Primeiro uso no comércio

02/06/2014

Código do desenho

4

Tipo de titular

03

Localização do titular

San Diego, CA

Examinador

SHANOSKI,JOANNA MARIE

Unidade examinadora

L40

Titulares e representantes

Titulares

MedImpact Healthcare Systems, Inc.
MedImpact Healthcare System, Inc.

Representantes

Susan B. Meyer Gordon Rees Scully Mansukhani LLP

Classificação técnica

Classes Nice

Classe 35Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Pharmaceutical servicesadministeringprocessingfulfillingtracking on-line prescription and over-the-counter medication orders; administeringprocessingfulfillingtracking orders for durable medical equipmentmedical suppliesmedical services; soliciting and accepting bids for filling prescription and over-the-counter medicationdurable medical equipmentmedical suppliesmedical services orders; administering an order fulfillment program comprised of a network of medical services providerspharmaciesmedical equipment and medical supply providers

Classe 42

Providing temporary use of on-line non-downloadable software for solicitation and placement of bids for filling prescription and over-the-counter medication ordersdurable medical equipment ordersmedical supply ordersprovision of medical services; providing temporary use of on-line non-downloadable software for administeringprocessingfulfillingtracking on-line prescription and over-the-counter medication orders; providing temporary use of on-line non-downloadable software for administeringprocessingfulfillingtracking orders for durable medical equipmentmedical suppliesmedical services; providing temporary use of on-line non-downloadable software for providing patient-specific information related to medicationmedical equipment and suppliesmedical services; providing temporary use of on-line non-downloadable software for organizing and administering a network of medical services providerspharmaciesmedical equipment and medical supply providers

Classe 44

Providing a website featuring patient information and patient consultation in the fields of healthwellnessmedicationmedical supplies and medical equipment for treatment purposes; providing information and consultation services to patients in the fields of healthwellnessmedicationmedical supplies and medical equipment for treatment purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

30/04/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/04/2024

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/04/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/04/2024

E815

TEAS SECTION 8 & 15 RECEIVED

11/10/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

29/08/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

15/08/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/08/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/08/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/08/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

15/08/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

29/08/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

25/07/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

24/07/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

21/07/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

14/07/2017

IUAF

USE AMENDMENT FILED

19/06/2017

EISU

TEAS STATEMENT OF USE RECEIVED

19/06/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

19/06/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

20/12/2016

CHPB

POST PUBLICATION AMENDMENT - ENTERED

25/10/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/10/2016

PUBO

PUBLISHED FOR OPPOSITION

25/10/2016

APET

ASSIGNED TO PETITION STAFF

12/10/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/10/2016

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

27/09/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/09/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

13/09/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

13/09/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

13/09/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

13/09/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/08/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

29/04/2016

GNRT

NON-FINAL ACTION E-MAILED

29/04/2016

CNRT

NON-FINAL ACTION WRITTEN

29/04/2016

DOCK

ASSIGNED TO EXAMINER

27/04/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

19/01/2016

NWAP

NEW APPLICATION ENTERED

15/01/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MEDIMPACT DIRECT SPECIALTY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.